Quanta Therapeutics

Quanta Therapeutics is a biotech company in United States. It has raised $50.0M across 2 rounds, most recently a $50.0M Series D in May 2023.

Conformational Blockade of RAS in Cancer

Business Model
B2B
Total Funding
$50.0M
Last Round
$50.0M Series DMay 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Quanta Therapeutics is a private biopharmaceutical company pioneering allosteric modulation to restore conformational control of active RAS signaling at the cell membrane and treat RAS-driven cancers. Using a proprietary Second Harmonic Generation platform, the company discovers oral small molecules against previously undruggable KRAS mutations, with a pipeline that includes QTX3034, a G12D-preferring multi-KRAS inhibitor in Phase 1 trials for pancreatic, colorectal, and endometrial cancers. Quanta's programs target a broad spectrum of RAS-driven tumors of the colon, pancreas, and lung, with potential as monotherapies and combination therapies.

Summary

It has raised $50.0M in total across 2 rounds, most recently a $50.0M Series D round in May 2023. Investors include Longitude Capital and BVF Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series DSeries DMay 2023
$50.0M

Sign up to see all 2 events

Funding: Venture Round through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Quanta Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/quanta-therapeutics"><img src="https://indexed.vc/api/badge/company/quanta-therapeutics" alt="Quanta Therapeutics on Indexed.vc" width="260" height="76" /></a>